$SIGA
SIGA Technologies Inc Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923012593 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$5.878M	$8.323M
YoY Change	-64.73%	-21.03%
Cost Of Revenue	$974.4K	$1.150M
YoY Change	10.47%	-75.63%
Gross Profit	$4.904M	$7.173M
YoY Change	-68.93%	23.26%
Gross Profit Margin	83.42%	86.18%
Selling, General & Admin	$4.426M	$4.235M
YoY Change	-24.65%	20.38%
% of Gross Profit	90.26%	59.04%
Research & Development	$5.116M	$5.046M
YoY Change	-25.2%	42.27%
% of Gross Profit	104.33%	70.35%
Depreciation & Amortization	$133.7K	$100.0K
YoY Change	3.85%	0.0%
% of Gross Profit	2.73%	1.39%
Operating Expenses	$9.542M	$9.281M
YoY Change	-24.95%	31.37%
Operating Profit	-$4.638M	-$2.108M
YoY Change	-251.05%	46.52%
Interest Expense	$0.00	$0.00
YoY Change	-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$1.191M	$890.6K
YoY Change	1545.23%	3718.84%
Pretax Income	-$3.448M	-$1.218M
YoY Change	-207.99%	14.39%
Income Tax	-$600.0K	-$300.0K
% Of Pretax Income
Net Earnings	-$2.875M	-$918.3K
YoY Change	-241.16%	154.33%
Net Earnings / Revenue	-48.92%	-11.03%
Basic Earnings Per Share	-$0.04	-$0.01
Diluted Earnings Per Share	-$0.04	-$0.01
COMMON SHARES
Basic Shares Outstanding	71.27M	72.20M
Diluted Shares Outstanding	71.09M	72.20M

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$76.21M	$115.7M
YoY Change	-33.46%	-24.52%
Cash & Equivalents	$76.21M	$115.7M
Short-Term Investments
Other Short-Term Assets	$1.561M	$1.959M
YoY Change	-49.38%	-12.29%
Inventory	$50.50M	$42.58M
Prepaid Expenses
Receivables	$6.027M	$12.32M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$134.3M	$172.5M
YoY Change	-12.59%	-2.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.605M	$1.717M
YoY Change	-23.91%	-23.29%
Goodwill	$898.3K	$898.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.117M	$2.041M
YoY Change	749.77%	669.02%
Total Long-Term Assets	$12.21M	$11.39M
YoY Change	93.94%	53.15%
TOTAL ASSETS
Total Short-Term Assets	$134.3M	$172.5M
Total Long-Term Assets	$12.21M	$11.39M
Total Assets	$146.5M	$183.9M
YoY Change	-8.4%	-0.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.081M	$1.140M
YoY Change	-10.97%	-35.9%
Accrued Expenses	$17.89M	$16.00M
YoY Change	20.55%	243.86%
Deferred Revenue	$11.37M	$10.52M
YoY Change	61.68%	1226.02%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$18.99M	$18.48M
YoY Change	13.74%	155.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.449M	$3.354M
YoY Change	-0.83%	-64.95%
Total Long-Term Liabilities	$3.449M	$3.354M
YoY Change	-0.83%	-64.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.99M	$18.48M
Total Long-Term Liabilities	$3.449M	$3.354M
Total Liabilities	$22.44M	$21.83M
YoY Change	11.23%	29.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$110.8M	-$72.28M
YoY Change	18.91%	23.14%
Common Stock	$234.9M	$234.4M
YoY Change	0.83%	3.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$124.1M	$162.1M
YoY Change
Total Liabilities & Shareholders Equity	$146.5M	$183.9M
YoY Change	-8.4%	-0.34%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$2.875M	-$918.3K
YoY Change	-241.16%	154.33%
Depreciation, Depletion And Amortization	$133.7K	$100.0K
YoY Change	3.85%	0.0%
Cash From Operating Activities	-$3.580M	$24.45M
YoY Change	62.16%	-56.89%
INVESTING ACTIVITIES
Capital Expenditures	$21.69K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$21.69K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-35.87M	-$7.557M
YoY Change	-1.8%	14.76%
NET CHANGE
Cash From Operating Activities	-3.580M	$24.45M
Cash From Investing Activities	-21.69K	$0.00
Cash From Financing Activities	-35.87M	-$7.557M
Net Change In Cash	-39.47M	$16.89M
YoY Change	1.91%	-66.3%
FREE CASH FLOW
Cash From Operating Activities	-$3.580M	$24.45M
Capital Expenditures	$21.69K	$0.00
Free Cash Flow	-$3.602M	$24.45M
YoY Change	63.15%	-56.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1848314	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6733810	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6250385	usd
CY2023Q1	us-gaap	Goodwill Goodwill	898334	usd
CY2022Q4	us-gaap	Goodwill Goodwill	898334	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2041240	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	252546	usd
CY2023Q1	us-gaap	Assets Assets	183924259	usd
CY2022Q4	us-gaap	Assets Assets	195035923	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1139853	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3355268	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16001327	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16852781	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71535268
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71535268
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72675190
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72675190
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.45
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-23047
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3864870
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	31 East 62nd Street
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10065
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	672-9100
CY2023Q1	dei	Security12b Title Security12bTitle	common stock, $.0001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	SIGA
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71267868
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	115680683	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98790622	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1335311	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1309672	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	18476491	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12316704	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45406960	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	42577787	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	39273090	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1958508	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2315672	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	172533682	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	185786344	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1717193	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21517721	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	3354308	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	3358160	usd
CY2023Q1	us-gaap	Liabilities Liabilities	21830799	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-483425	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1612534	usd
CY2022Q4	us-gaap	Liabilities Liabilities	24875881	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	7154	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7268	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	234366497	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	233957767	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72280191	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63804993	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	162093460	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	170160042	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	183924259	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195035923	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8323025	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10539299	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1150187	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4720116	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4235108	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3711288	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5046036	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3546776	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	10431331	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	11978180	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2108306	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1438881	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	351104	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	890629	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	23322	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1217677	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1064455	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-299422	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-703406	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-918255	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-361049	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72197038
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73070565
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72197038
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73883058
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-918255	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-361049	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	131121	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	127526	usd
CY2023Q1	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	-0	usd
CY2022Q1	siga	Gain Loss On Change In Fair Value Of Warrant Liability GainLossOnChangeInFairValueOfWarrantLiability	351104	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	408730	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	368754	usd
CY2023Q1	siga	Inventory Write Down Net Of Credits InventoryWriteDownNetOfCredits	0	usd
CY2022Q1	siga	Inventory Write Down Net Of Credits InventoryWriteDownNetOfCredits	135471	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-33090256	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-78311550	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3304697	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3097407	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1431530	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-241607	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3011077	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1881714	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	25639	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-18398271	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-59644	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2971232	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24447118	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	56706411	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	-0	usd
CY2022Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12533	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7557057	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6572783	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7557057	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6585316	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	16890061	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	50121095	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	98790622	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103138819	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115680683	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153259914	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	64900000	usd
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5100000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	351104	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-918255	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-712153	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72197038
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8514450	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6370581	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	27999164	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	27038845	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6064173	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5863664	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	42577787	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	39273090	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6894863	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6894863	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5177670	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5046549	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1717193	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1848314	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73070565
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10521502	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10581146	usd
CY2023Q1	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	2150952	usd
CY2022Q4	siga	Accrued Research And Development Vendor Costs Current AccruedResearchAndDevelopmentVendorCostsCurrent	1551920	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1343521	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1276513	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	801890	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2378035	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	646835	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	536997	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16001327	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16852781	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-918255	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-361049	usd
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	812493
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72197038
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73883058
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	29300000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8323025	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10539299	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1933786	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1200000	usd
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1100000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-700000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.246	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.661	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	170160042	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-918255	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	7557057	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	408730	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	162093460	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174314407	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-361049	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6572783	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	12533	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	368754	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	167736796	usd
CY2021Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	447751	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	678627	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	406994	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	409971	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165916	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2109259	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	175473	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001437749-23-012593-index-headers.html	Edgar Link	pending
0001437749-23-012593-index.html	Edgar Link	pending
0001437749-23-012593.txt	Edgar Link	pending
0001437749-23-012593-xbrl.zip	Edgar Link	pending
ex_463926.htm	Edgar Link	pending
ex_463927.htm	Edgar Link	pending
ex_463928.htm	Edgar Link	pending
ex_463929.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20230331.xsd	Edgar Link	pending
siga20230331_10q.htm	Edgar Link	pending
siga-20230331_cal.xml	Edgar Link	unprocessable
siga-20230331_lab.xml	Edgar Link	unprocessable
siga-20230331_def.xml	Edgar Link	unprocessable
siga-20230331_pre.xml	Edgar Link	unprocessable
siga20230331_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA Technologies Inc Stock $siga

2023 Q2 Form 10-Q Financial Statement

#000143774923012593 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA Technologies Inc Stock $siga

2023 Q2 Form 10-Q Financial Statement

#000143774923012593 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA Technologies Inc Stock $siga